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Proskocil BJ, Bruun DA, Jacoby DB, van Rooijen N, Lein
PJ, Fryer AD. Macrophage TNF- mediates parathion-induced
airway hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol
Physiol 304: L519 –L529, 2013. First published February 1, 2013;
doi:10.1152/ajplung.00381.2012.—Organophosphorus pesticides
(OPs) are implicated in human asthma. We previously demonstrated
that, at concentrations that do not inhibit acetylcholinesterase activity,
the OP parathion causes airway hyperreactivity in guinea pigs as a
result of functional loss of inhibitory M2 muscarinic receptors on
parasympathetic nerves. Because macrophages are associated with
asthma, we investigated whether macrophages mediate parathion-
induced M2 receptor dysfunction and airway hyperreactivity. Airway
physiology was measured in guinea pigs 24 h after a subcutaneous
injection of parathion. Pretreatment with liposome-encapsulated clo-
dronate induced alveolar macrophage apoptosis and prevented para-
thion-induced airway hyperreactivity in response to electrical stimu-
lation of the vagus nerves. As determined by qPCR, TNF- and IL-1
mRNA levels were increased in alveolar macrophages isolated from
parathion-treated guinea pigs. Parathion treatment of alveolar macro-
phages ex vivo did not significantly increase IL-1 and TNF-
mRNA but did significantly increase TNF- protein release. Consis-
tent with these data, pretreatment with the TNF- inhibitor etanercept
but not the IL-1 receptor inhibitor anakinra prevented parathion-
induced airway hyperreactivity and protected M2 receptor function.
These data suggest a novel mechanism of OP-induced airway hyper-
reactivity in which low-level parathion activates macrophages to
release TNF--causing M2 receptor dysfunction and airway hyperre-
activity. These observations have important implications regarding
therapeutic approaches for treating respiratory disease associated with
OP exposures.
airway hyperreactivity; alveolar macrophages; organophosphorus pes-
ticides; parathion; tumor necrosis factor-
ORGANOPHOSPHORUS PESTICIDES (OPs) are the most widely used
insecticides in the United States and throughout the world (45),
both in agriculture (30) and in residential and urban commu-
nities (33). An early study reported that OP metabolites were
detected in the urine of 99% of a cohort of Seattle children
(33), and subsequent studies have reported that a mixture of
pesticide residues are detected in the blood and/or urine of
nearly all persons sampled in the United States (3). Increased
use of OPs over the last two decades correlates with increased
incidence of asthma, particularly in children (20). Both epide-
miological and clinical studies have shown an association
between OP exposure and symptoms of asthma, including
wheezing and increased airway responsiveness (9, 22, 23).
OPs also increase airway reactivity in animal models (48).
In guinea pigs, we have shown that a single subcutaneous
injection of phosphorothionate OPs, specifically diazinon,
chlorpyrifos, or parathion, causes airway hyperreactivity 24
h later, and, at least for chlorpyrifos, this effect persists for
at least 7 days (14, 32, 41).
The primary mechanism of acute OP intoxication is inhibi-
tion of acetylcholinesterase (AChE) activity, the enzyme re-
sponsible for hydrolyzing acetylcholine (ACh). Significant
inhibition of AChE activity causes airway smooth muscle
contraction and excessive mucus secretion. However, we have
demonstrated that diazinon, chlorpyrifos, and parathion cause
airway hyperreactivity in guinea pigs at doses too low to inhibit
AChE activity (14, 32, 41). OPs target enzymes and receptors
other than AChE, including cholinergic receptors (39, 47, 51).
In lungs, postganglionic parasympathetic nerves release ACh
onto M3 muscarinic receptors on airway smooth muscle, caus-
ing contraction, resulting in bronchoconstriction. ACh activa-
tion of inhibitory M2 muscarinic receptors located prejunction-
ally on parasympathetic nerves decreases ACh release and
limits vagally induced bronchoconstriction (15). M2 musca-
rinic receptors are dysfunctional in some humans with asthma
(34) and in animal models of antigen-, virus-, and ozone-
induced airway hyperreactivity (12, 16, 18). Although OPs are
reported to inhibit muscarinic receptor function in brain (28),
we were unable to show a direct interaction between parathion
or its oxon metabolite with M2 muscarinic receptor expression
or function in autonomic neurons (42). These data suggest that
parathion causes neuronal M2 muscarinic receptor dysfunction
and airway hyperreactivity via an intermediary cell type, which
then in turn impacts parasympathetic nerve function in the
airways.
Alveolar and interstitial macrophages are the main immune
cell type throughout the lung. In asthmatics, numbers of mac-
rophages, as well as eosinophils and T cells (40), are increased,
and monocyte chemoattractant protein is elevated (46). Mac-
rophages release TNF- and IL-1, both of which are in-
creased in the lungs of asthmatics and in animal models of
hyperreactivity (5, 7). In experimental models, administration
of TNF- or IL-1 enhances airway reactivity (29, 57). Con-
versely, blocking TNF- or IL-1 with specific antagonists
prevents airway hyperreactivity caused by antigen and other
environmental triggers, such as ozone (35, 49, 56). TNF- and
IL-1 and other macrophage factors can decrease M2 musca-
rinic receptor function or expression (35). OPs and related
organophosphate nerve agents, given to animals at low doses,
affect isolated monocytes and macrophages, increasing respi-
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ratory burst capacity (44) and decreasing phagocytic activity
(27). However, whether OPs similarly influence macrophage
function in vivo has not been reported. OPs and related or-
ganophosphate nerve agents have been demonstrated to in-
crease mRNA of interleukin-6, IL-1, and TNF- and increase
NF-B activation in whole lung (38), suggesting the possibility
of macrophage involvement. Thus we investigated whether
macrophages and these inflammatory pathways contribute to
OP-induced airway hyperreactivity.
Here we report that inducing macrophage apoptosis with
clodronate prevents parathion-induced airway hyperreactivity.
Furthermore, parathion increases TNF- and IL-1 expression
in macrophages isolated from the lungs, and blocking TNF-,
but not IL-1, prevents parathion-induced airway hyperreac-
tivity and neuronal M2 muscarinic receptor dysfunction.
MATERIALS AND METHODS
Animals. Young adult, pathogen-free female Hartley guinea pigs
(300–375 g) were obtained from Elm Hill Laboratory (Chelmsford,
MA). Guinea pigs were shipped in filtered crates, housed in rooms
with air filtered using high-efficiency particulate absorbers, and fed
standard guinea pig diet (Prolab; Agway, Syracuse, NY). Guinea pigs
were treated humanely in accordance with standards established by
the U.S. Animal Welfare Act set forth by National Institutes of Health
guidelines. All protocols were approved by the Animal Care and Use
Committee at Oregon Health and Science University.
Animal pretreatments. Clodronate, a gift of Roche Diagnostics
(Mannheim, Germany), was used to induce alveolar macrophage
apoptosis (53). Liposome-encapsulated clodronate (7 mg clodronate/
ml) and liposome-encapsulated PBS were prepared as previously
described (54). On day 1, liposome-encapsulated clodronate or lipo-
some-encapsulated PBS was administered intranasally (i.n.; 0.3 ml)
and i.p. (1 ml), and, on day 3, liposomes were administered again i.n.
(0.3 ml). On day 4, guinea pigs were treated with 1.0 mg/kg s.c.
parathion (o,o-diethyl-o-p-nitrophenyl phosphorothioate, 99.5% pure;
Chem Service, West Chester, PA) in peanut oil or an equivalent
volume (300 l) of peanut oil (vehicle controls) injected into the
subscapular region (32). Subcutaneous dosing results in slow sus-
tained pesticide release into the systemic circulation (50), approxi-
mating human dermal exposure (17). Animals were monitored 1, 4,
and 24 h after pesticide administration for signs of cholinergic
intoxication (tremors, altered gait, and excessive excretions), none of
which were observed. Recombinant human IL-1 receptor antagonist
anakinra (Kineret; Amgen, Thousand Oaks, CA) was diluted in PBS,
and either 30 mg/kg anakinra or PBS (control) was administered i.p.
30 min before s.c. parathion or peanut oil. TNF- inhibitor, etanercept
(Enbrel; Amgen), was diluted in PBS, and either 3 mg/kg etanercept
or PBS (control) was administered i.p. 24 h before s.c. parathion or
peanut oil. Doses and timing of anakinra (49, 56) and etanercept (35)
were chosen based on their effectiveness in preventing airway hyper-
reactivity in other guinea pig asthma models.
Measurement of pulmonary inflation pressure and bradycardia.
Physiological measurements of lung function were performed 24 h
after parathion administration as previously described (13). Guinea
pigs were anesthetized with urethane (1.7–1.9 g/kg, i.p.; Sigma-
Aldrich, St. Louis, MO). Depth of anesthesia was determined by a
foot pinch and a touch to the inner corner of the eye. Both jugular
veins were cannulated for i.v. drug administration. A carotid artery
was cannulated and attached to a pressure transducer (BD Biosci-
ences, San Jose, CA) to measure heart rate and blood pressure. These
recordings were also used to monitor the depth of anesthesia after
neuromuscular blockade. Guinea pigs were tracheostomized, cannu-
lated, paralyzed with succinylcholine (10 g·kg1·min1, i.v.; Sigma-
Aldrich), and ventilated with positive pressure and constant volume (1
ml/100 g body wt and 100 breaths/min). Guanethidine (2 mg/kg, i.v.;
Sigma-Aldrich) was used to deplete noradrenaline. Both vagus nerves
were cut and distal ends placed on platinum electrodes. Pulmonary
inflation pressure (mmH2O) was measured with a pressure transducer
off a side arm of the tracheal cannula. Electrical stimulation of the
vagus nerves (1–15 Hz, 10 V, 0.2 ms, for 5 s at 40–60-s intervals)
induced bradycardia and bronchoconstriction that was measured as a
decrease in beats per minute and an increase in pulmonary inflation
pressure, respectively, as previously described (13). Treatment with
parathion, liposome-encapsulated clodronate, liposome-encapsulated
PBS, etanercept, or anakinra independently or in combination had no
effect on baseline pulmonary inflation pressure, baseline heart rate, or
baseline blood pressure in age-matched guinea pigs (Table 1).
Measurement of M2 receptor function. M2 muscarinic receptor
function was measured using the selective M2 receptor antagonist
gallamine in animals separate from those used to measure vagally
Table 1. Baseline physiological values in age-matched guinea pigs
Baseline Values Weight, g Ppi, mmH2O Heart Rate, bpm Systolic BP, mmHg Diastolic BP, mmHg
Clodronate (n  4–7) [Figure 1]
PBSlip 358.6  6.4 101.4 2.6 279.3 10.6 44.6  2.1 23.7  2.1
Cldlip 370.5  11.0 97.5 5.3 294.4 7.7 42.3  2.8 22.0  2.1
PBSlip  Pth 366.0  9.6 101.1 4.2 297.2 8.1 49.8  2.2 25.6  2.4
Cldlip  Pth 354.6  6.8 103.0 5.8 285.5 8.1 40.0  1.4 19.2  1.1
Anakinra (n  6–7) [Figure 6]
Control 360.4 11.0 98.6 1.4 283.6 16.5 50.6  2.1 18.3  1.7
Ank 366.3 5.6 93.3 5.6 241.7 6.1 40.7  3.0 12.3  2.0
Pth 366.1 5.6 91.4 3.4 269.3 15.4 52.6  4.8 16.0  1.6
Ank  Pth 359.5  8.9 101.7 4.8 284.2 12.3 52.0  1.9 17.0  1.7
Etanercept (n  5–7) [Figure 7]
Control 369.5 11.7 95.0 3.4 287.5 6.4 47.7  3.4 21.0  2.2
Etn 387.3 4.1 90.0 2.2 267.9 15.8 48.6  1.0 22.9  3.1
Pth 365.1 9.8 100.0 4.4 280.7 8.0 50.6  2.6 22.3  1.8
Etn  Pth 380.3  11.1 92.5 2.5 283.1 15.5 44.0  4.2 24.5  2.9
M2 function Etanercept (n  5–6) [Figure 10]
Control 356.0 14.1 91.7 3.1 282.5 17.3 45.3  4.4 17.3  2.2
Etn 346.2 3.4 94.0 6.0 254.0 12.0 45.2  3.0 14.8  1.6
Pth 352.8 5.6 88.3 7.0 291.7 10.0 42.0  0.9 16.7  1.8
Etn  Pth 340.3  7.5 95.5 6.7 261.7 17.5 48.0  2.7 16.0  1.5
Data are presented as means  SE. Ank, anakinra; Cldlip, liposome-encapsulated clodronate; Etn, etanercept; PBSlip, liposome-encapsulated PBS (control);
Ppi, pulmonary inflation pressure; Pth, parathion.
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induced and ACh-induced airway reactivity. The distal ends of both
vagus nerves were stimulated at 15 Hz, 2–20 V, 0.2-ms pulse
duration, for 3 s at 40-s intervals until 10 consistent bronchoconstric-
tions of 10–25 mmH2O were measured (5 mmH2O difference)
above baseline inflation pressure. The last five bronchoconstrictions
were averaged to obtain a baseline. Gallamine (0.1, 0.3, 1.0, 3.0, and
10 mg/kg) was administered i.v., and four bronchoconstrictions were
measured after each gallamine dose and averaged. The effect of
gallamine on M2 receptor function was assessed as the ratio of mean
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Fig. 1. Pretreatment with liposome-encapsulated clodronate (Cldlip) prevented
parathion (Pth)-induced airway hyperreactivity. A: electrical stimulation of the
vagus nerves caused frequency-dependent bronchoconstriction that was similar
in guinea pigs pretreated with either liposome-encapsulated PBS (PBSlip) or
Cldlip. Parathion (1.0 mg/kg, s.c.) significantly potentiated vagally induced
bronchoconstriction in animals pretreated with PBSlip. Cldlip pretreatment
prevented parathion potentiation of vagally induced bronchoconstriction (n 
4–7). B: electrical stimulation of the vagus nerves caused frequency-dependent
bradycardia that was not affected by parathion or Cldlip, administered inde-
pendently or in combination (n  4–5). Data are presented as means  SE
(*P 	 0.05). Ppi, pulmonary inflation pressure; HR, heart rate.
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Fig. 2. Pretreatment with Cldlip had no effect on acetylcholine-induced bron-
choconstriction or acetylcholinesterase (AChE) activity. A: ACh (1–10 g/kg,
i.v.) induced dose-dependent bronchoconstriction. Treatment with parathion or
Cldlip independently or in combination had no effect on ACh-induced bron-
choconstriction relative to animals treated with PBSlip (n 4–7). B: treatment
with Cldlip or parathion independently or in combination did not inhibit
AChE activity in lung or blood relative to levels observed in the same
tissues from guinea pigs treated with PBSlip (n  3). Data are presented as
means  SE.
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bronchoconstriction after each dose of gallamine to the mean bron-
choconstriction before gallamine. Voltages were not significantly
different between groups (data not shown).
AChE activity assay. PBS-perfused lung and brain tissue and
heparinized blood were collected and measured for AChE activity
using the Ellman assay (10) as previously described (32).
Bronchoalveolar lavage. In experiments that did not involve cul-
turing bronchoalveolar lavage (BAL) macrophages, BAL fluid was
collected immediately following physiological experiments using five
aliquots of 10 ml PBS (room temperature). Cells were centrifuged for
10 min at 300 g and resuspended in 20 ml PBS. Cells were counted
on a hemocytometer to obtain total cell counts and cytospun onto
slides and stained with Hemacolor (EMD Chemicals, Philadelphia,
PA) to obtain differential cell counts.
Culturing alveolar macrophages. BAL was performed as described
above with the exception that antibiotics (100 I.U. penicillin/ml and
100 g/ml streptomycin; Mediatech, Manassas, VA) were added to
sterile PBS (4°C). BAL fluid was centrifuged for 10 min at 300 g, and
cells were resuspended in RPMI-1640 media (Cellgro 15-040-CV;
Mediatech) containing glutamine (2 M; Invitrogen, Carlsbad, CA),
antibiotics, and 10% heat-inactivated fetal bovine serum (Hyclone
30071.63; Thermo Scientific, Waltham, MA). All BAL cells were
plated into tissue culture dishes and incubated for 1 h at 37°C at 95%
O2-5% CO2. After 1 h, nonadherent cells were gently dislodged and
removed, leaving adherent macrophages (
95% purity as identified
by Hemacolor stain; EMD Chemicals). Alveolar macrophages used
for mRNA analysis were isolated and cultured from parathion- or
control-treated treated guinea pigs following physiological experi-
ments and frozen (80°C) for RNA isolation (see below).
Caspase-3 activity assay. Alveolar macrophages were cultured
from the BAL of animals treated with liposome-encapsulated PBS or
liposome-encapsulated clodronate. Macrophages were rinsed with
PBS, lysed with 0.4 ml lysis buffer [10 mM Tris·HCl, 10 mM
NaH2PO4/Na2HPO4 (pH 7.5), 130 mM NaCl, 1% Triton X-100, 10
mM Na pyrophosphate in sterile H2O], and stored at 80°C until
used. Lysed macrophages were thawed and centrifuged. For both
control (no cell lysate) and macrophage cell lysate samples, a dupli-
cate sample was treated with caspase inhibitor (10 M AC-DEVD-
CHO; Sigma-Aldrich) for 30 min on ice. A caspase-3 fluorogenic
substrate (20 M AC-DEVD-AMC; BD Biosciences) was added to
each sample. Samples were loaded in a 96-well plate in duplicate and
incubated for 1 h at 37°C. The 7-amino-4-methylcoumarin standard
(Sigma-Aldrich) was serially diluted in cell lysis buffer and loaded in
duplicate in the same 96-well plate. The plate was read on a spectro-
fluorometer with an excitation wavelength of 380 nm and an emission
wavelength of 430–460 nm. Background fluorescence (averaged
from the control sample) was subtracted from each sample.
Alveolar macrophages exposed to parathion and paraoxon ex vivo.
Macrophages were isolated from BAL (as described above) collected
from control anesthetized guinea pigs not used in physiological
experiments. Stock parathion and paraoxon (Chem Service) were
diluted first in DMSO and subsequently in phenol-free RPMI media.
Parathion (100 M), paraoxon (100 nM), or 0.1% DMSO (control)
was added to the macrophages for 24 h before the conditioned
medium was collected for ELISA assay (see below) and mRNA was
isolated from the cells. All experiments were run in triplicate.
qPCR. Alveolar macrophage RNA was isolated using the RNeasy
Mini Kit (Qiagen, Valencia, CA). RNA was reverse transcribed with
SuperScript III (Invitrogen) using random hexamers. cDNA (1 l of
1:100 dilution for 18S and 2 l of 1:10 dilution for IL-1 and TNF-)
was amplified for 40 cycles at an annealing temperature of 59°C using
QuantiTect SYBR Green (Qiagen) in duplicate using the 7500 Fast
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Fig. 3. Pretreatment with Cldlip increased caspase-3 activity in alveolar macrophages but did not deplete the number of alveolar or interstitial macrophages.
A: caspase-3 activity was measured in alveolar macrophages using a fluorogenic substrate and normalized to protein concentration. Pretreatment with Cldlip (n 
6) significantly increased caspase-3 activity in alveolar macrophages isolated from control or parathion-treated guinea pigs relative to alveolar macrophages
isolated from guinea pigs that received PBSlip (n  5). To confirm that the fluorescent signal was due to caspase activity, fluorescence was also quantified in
duplicate samples to which the caspase-3 inhibitor Ac-DEVD-CHO had been added. B: the number of macrophages and other inflammatory cells in the
bronchoalveolar lavage (BAL) was not changed by treatment with either parathion or Cldlip (n  7–9). As shown in a representative photomicrograph from a
guinea pig that received Cldlip (C), interstitial lung macrophages were identified by calprotectin immunoreactivity (bar  100 m). D: the number of interstitial
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Real-Time PCR System (Applied Biosystems, Carlsbad, CA). PCR
products were quantified on the Mx3000P real-time PCR System (Strat-
agene, Wilmington, DE). Specific PCR primers for 18S, IL-1, and
TNF- were synthesized (Integrated DNA Technologies, Coralville, IA)
as follows: 18S rRNA 5= GTAACCCGTTGAACCCCATT and 18S
rRNA 3= CCATCCAATCGGTAGTAGCG; guinea pig IL-1 5= CTTT-
GAAGAAGAGCCCATCG and guinea pig IL-1 3= CGAAGCT-
CATGGAGAACACC; and guinea pig TNF- 5= CCTACCTGCTTCT-
CACCCATACC and guinea pig TNF- 3= TTGATGGCAGAGAAG-
GTTGA. For each gene product, a linear regression formula was
generated by plotting the log nanogram of input RNA vs. the critical
threshold (CT) value obtained from a serial dilution of a random
cDNA sample (6). Using this standard curve, the CT values for each
sample were converted to relative mRNA concentrations. The relative
amount of mRNA for each gene product was normalized to the
relative amount of 18S mRNA expression for that particular sample.
ELISA. Guinea pig IL-1 and TNF- were measured using com-
mercially available ELISA kits (R&D Systems, Minneapolis, MN).
Detection limits were 31.25 pg TNF-/ml and 62.5 pg IL-1/ml.
Macrophage immunohistochemistry and analysis. Guinea pig lungs
were removed, fixed in zinc formalin, and embedded in paraffin.
Staining of paraffin sections required using Antigen Unmasking
Solution (Vector Laboratories, Burlingame, CA), followed by quench-
ing of endogenous peroxidase with 3% hydrogen peroxide in metha-
nol. Nonspecific binding was blocked with 2.5% normal horse serum.
Macrophages in lung sections were identified using a primary anti-
body for calprotectin (1:1,000 MAC 387 antibody; AbD Serotec,
Raleigh, NC) and secondary anti-mouse ImmPRESS Reagent kit
(Vector Laboratories) with ImmPACT DAB (Vector Laboratories). In
each of four lung sections from each animal, 19–25 randomly selected
views of lung parenchyma encompassing the entire section were
photographed at 10 (CoolSNAP; PhotoMetrics, Huntington Beach,
CA) using the Metamorph Imaging System (Universal Imaging,
Downingtown, PA). For each picture, MAC 387-positive cells were
manually counted (avoiding labeled monocytes in blood vessels) by
experimenters blinded to the experimental condition. The number of
MAC 387-positive cells per field of view in the four lung sections was
averaged for each animal.
Data analysis. Frequency and dose response curves of vagally
induced and ACh-induced bronchoconstriction and bradycardia and
gallamine dose response curves were analyzed by repeated-measures
two-way ANOVA. BAL and blood differential counts, AChE activity,
and macrophage immunohistochemistry were analyzed by one-way
ANOVA with post hoc Bonferroni correction. Real-time quantifica-
tion of BAL macrophages treated with parathion ex vivo and TNF-
ELISA were analyzed by one-way ANOVA with post hoc Dunnett’s
multiple-comparison test. Caspase-3 activity and real-time PCR quan-
tification of BAL macrophages treated with parathion in vivo were
analyzed using an unpaired, one-tailed Student’s t-test. Statistical
probability of P  0.05 was considered significant. Data are repre-
sented as means  SE.
RESULTS
Clodronate pretreatment blocks parathion-induced airway
hyperreactivity. Electrical stimulation of the vagus nerves
caused frequency-dependent bronchoconstriction measured as
an increase in pulmonary inflation pressure (Fig. 1A) and
frequency-dependent decrease in heart rate (Fig. 1B) in animals
pretreated with PBS encapsulated in liposomes (controls).
Pretreatment with clodronate encapsulated in liposomes did not
change either vagally induced bronchoconstriction or vagally
induced bradycardia relative to the controls. Consistent with
our previous studies (14, 32, 41), parathion significantly in-
creased vagally mediated bronchoconstriction in animals pre-
treated with PBS liposomes. In contrast, this parathion-induced
hyperresponsiveness was completely prevented by pretreating
guinea pigs with clodronate liposomes (Fig. 1A). Neither para-
thion nor clodronate, alone or in combination, had any effect
on vagally induced bradycardia (Fig. 1B).
Neither parathion nor clodronate affected airway smooth
muscle responsiveness. Direct stimulation of M3 muscarinic
receptors on airway smooth muscle via intravenous ACh
caused dose-dependent bronchoconstriction in all treatment
groups. ACh-induced bronchoconstriction was not different
between control and parathion-treated guinea pigs in the ab-
sence or presence of clodronate (Fig. 2A). Neither liposome
treatment nor parathion inhibited AChE activity in blood or
lung relative to controls (Fig. 2B).
Effects of clodronate and parathion on macrophages in the
lung. To confirm that clodronate was targeting macrophages,
caspase-3 activity was measured in alveolar macrophages iso-
lated from guinea pig BAL. As shown in Fig. 3A, caspase-3
activity was significantly increased in macrophages obtained
from guinea pigs treated with clodronate liposomes compared
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Fig. 4. TNF- and IL-1 mRNA expression in BAL macrophages isolated
from guinea pigs treated with parathion. RNA was isolated from BAL
macrophages collected from guinea pigs 24 h after administration of parathion
(1.0 mg/kg, s.c.) or an equal volume of peanut oil (vehicle control). As
determined by qPCR, parathion significantly increased TNF- (A) and IL-1
(B) mRNA expression in BAL macrophages (n  5–7). Data are presented as
means  SE (*P  0.05).
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with guinea pigs treated with PBS liposomes. Clodronate
increased caspase-3 activity independent of parathion treat-
ment (Fig. 3A, { and o). Addition of a caspase-3 inhibitor to
the isolated macrophages completely inhibited the signal, con-
firming that the assay was measuring caspase-3 activity (Fig.
3A,, }, Œ, and). Neither parathion nor clodronate affected
inflammatory cell numbers in the BAL (Fig. 3B). Clodronate
also did not change the number of lung interstitial macrophages
as identified by calprotectin immunoreactivity (Fig. 3, C–D).
Effects of parathion and paraoxon on proinflammatory cy-
tokine expression in alveolar macrophages. Both TNF- and
IL-1 mRNA were significantly increased in alveolar macro-
phages isolated from guinea pigs treated with parathion com-
pared with peanut oil (vehicle) controls (Fig. 4). When alveolar
macrophages were isolated from untreated guinea pigs and
exposed ex vivo to parathion for 24 h, no significant changes
were detected in transcript levels of either TNF- (Fig. 5A) or
IL-1 (Fig. 5B). In contrast, TNF- protein was significantly
increased in conditioned media from these same cells (Fig.
5C). IL-1 protein was not detected in conditioned media, and
neither IL-1 nor TNF- proteins were detected in the BAL
fluid by ELISA (data not shown). Ex vivo exposure to the oxon
metabolite of parathion, paraoxon, had no effect on alveolar
macrophage levels of TNF- mRNA (Fig. 5A), IL-1 mRNA
(Fig. 5B), or TNF- protein (Fig. 5C). Thus production of
TNF- protein was increased by parathion but not by the more
active metabolite paraoxon, consistent with inhibition of cho-
linesterase activity not being central to this effect.
The IL-1 receptor inhibitor anakinra did not prevent parath-
ion-induced airway hyperreactivity. Electrical stimulation of the
vagus nerves caused frequency-dependent bronchoconstriction
that was not changed by pretreatment with 30 mg/kg anakinra
(Fig. 6A). Parathion significantly potentiated vagally induced
bronchoconstriction, and this parathion-induced airway hyper-
reactivity was not prevented by anakinra pretreatment (Fig.
6A). Intravenous ACh caused dose-dependent bronchoconstric-
tion (Fig. 6B). Neither anakinra nor parathion, alone or in
combination, affected airway smooth muscle responsiveness to
ACh (Fig. 6B). Neither parathion nor anakinra, alone or in
combination, affected total and differential counts of leuko-
cytes in the peripheral blood and BAL (data not shown). None
of these treatments altered blood, brain, and lung AChE rela-
tive to controls (data not shown).
The TNF- inhibitor etanercept prevented parathion-in-
duced airway hyperreactivity at the level of the parasympa-
thetic nerves. Electrical stimulation of the vagus nerves caused
frequency-dependent bronchoconstriction (Fig. 7A) and fre-
quency-dependent bradycardia (Fig. 7B). The potentiation of
vagally induced bronchoconstriction by parathion was pre-
vented by pretreatment with etanercept (Fig. 7A). Etanercept
had no effect on vagally induced bronchoconstriction in con-
trols. Vagally induced bradycardia was not significantly in-
creased by parathion (Fig. 7B). Intravenous ACh caused
dose-dependent bronchoconstriction and bradycardia that
was not altered by parathion or etanercept, either alone or in
combination (Fig. 7, C–D). Neither parathion, etanercept,
nor the combination affected AChE activity in lung, blood,
or brain that was collected following physiological experi-
ments (Fig. 8).
The effect of parathion and etanercept on BAL and blood
cells. Neither parathion, etanercept, nor the combination af-
fected the number of macrophages, lymphocytes, neutrophils,
eosinophils, or total number of cells in the BAL (Fig. 9A). In
the blood, monocytes, lymphocytes, neutrophils, and eosino-
phils were not affected by any treatment (Fig. 9B).
Etanercept inhibits parathion-induced M2 muscarinic dysfunc-
tion. The M2 muscarinic antagonist gallamine increased va-
gally induced bronchoconstriction in a dose-related manner in
control animals, demonstrating that M2 receptors were func-
tioning normally to inhibit ACh release (Fig. 10). In contrast,
the ability of gallamine to potentiate bronchoconstriction was
significantly inhibited in parathion-treated guinea pigs, indicat-
ing M2 receptor dysfunction (Fig. 10). The TNF- inhibitor
etanercept had no effect on gallamine-induced potentiation in
controls, but, in the presence of etanercept, parathion no longer
inhibited M2 receptor function (Fig. 10).
DISCUSSION
Consistent with our previous studies (14, 32, 41), parathion
potentiated vagally induced bronchoconstriction and caused
M2 receptor dysfunction on airway nerves in guinea pigs at a
dose that did not inhibit AChE. This same dose of parathion
caused significant M2 receptor dysfunction in airway nerves
but had no effect on any other physiological parameters mea-
sured, including animal weight, baseline pulmonary inflation
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Fig. 5. TNF- and IL-1 expression in guinea pig BAL macrophages treated ex vivo with parathion. BAL macrophages were cultured from naïve guinea pigs
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pressure, heart rate, and blood pressure. Also consistent with
previous data showing that airway hyperreactivity is indepen-
dent of BAL inflammatory cell number (11), parathion did not
increase the number of cells in the BAL. Parathion also had no
effect on bronchoconstriction induced by intravenous ACh.
Collectively, these data demonstrate that parathion-induced
airway hyperreactivity is mediated at the vagus nerves and is
not due to a postjunctional increase in airway smooth muscle
contraction.
M2 receptors are expressed prejunctionally on the vagus
nerve innervating the heart and postjunctionally on cardiac
myocytes. Parathion did not significantly increase bradycardia
in response to electrical stimulation or i.v. ACh, indicating the
M2 receptors in the heart were not affected by parathion. This
dissociation between a loss of M2 receptor function on lung
parasympathetic nerves but not heart parasympathetic nerves
has also been observed with virus- and antigen challenge-
induced airway hyperreactivity in guinea pigs (16, 36). These
data are consistent with other data indicating that M2 receptors
are differentially regulated in different tissues (19).
Whereas parathion caused a loss of M2 receptor function on
parasympathetic nerves, our previous studies indicated that
neither parathion nor its oxon metabolite, paraoxon, interact
directly with parasympathetic nerves to alter M2 receptor
expression, subcellular localization, or function (42). There-
fore, we hypothesized that parathion acts on an intermediate
cell type in the lung that subsequently influences the function
of airway nerves to cause airway hyperreactivity. The data
reported here identify alveolar macrophages as an intermediary
cell targeted by parathion. The most direct evidence supporting
a key role for alveolar macrophages is that parathion-induced
airway hyperreactivity was completely prevented by pretreat-
ing guinea pigs with liposome-encapsulated clodronate. Mac-
rophages phagocytize the liposomes containing clodronate, and
lysosomal phospholipases release clodronate into the cell,
inducing apoptosis (55). In rats and mice, intratracheal or
intranasal instillation of clodronate is effective at depleting
alveolar macrophages by 80–95% within 24 h (21, 52), and
this effect persists for at least 72 h (4, 54). Whereas pretreat-
ment with liposome-encapsulated clodronate clearly prevented
parathion-induced airway hyperreactivity in guinea pigs, we
were unable to demonstrate macrophage depletion in the BAL
or lung, even though it was administered by simultaneous
intranasal instillation and intraperitoneal injection. This is
consistent with our previous report of clodronate use in guinea
pigs (31). Clodronate did, however, induce apoptosis of alve-
olar macrophages. Caspase-3 activity, a marker of apoptosis,
was significantly increased in alveolar macrophages isolated
from clodronate-treated guinea pigs regardless of parathion
treatment. Thus, although clodronate did not decrease macro-
phage cell numbers, it is likely that, at the time when airway
hyperreactivity was measured, alveolar macrophages were ap-
optotic, suggesting that loss of macrophage function is the
mechanism underlying the protective effect of clodronate
against parathion-induced airway hyperreactivity.
Alveolar macrophages potentially modulate parathion-in-
duced airway hyperreactivity via release of soluble mediators
that cause neuronal M2 receptor dysfunction. Activated mac-
rophages release IL-1 and TNF-, both of which are associ-
ated with asthma and airway hyperresponsiveness (2, 7, 29, 57)
and have been shown to decrease M2 receptor expression (35).
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Fig. 6. Pretreatment with the IL-1 antagonist anakinra (Ank) had no effect on
parathion-induced airway hyperreactivity. A: electrical stimulation of the vagus
nerves caused frequency-dependent bronchoconstriction in control animals
that was not changed with anakinra (30 mg/kg, i.p.) treatment. Parathion (1.0
mg/kg, s.c.) significantly potentiated vagally induced bronchoconstriction, and
this effect was not blocked by pretreatment with anakinra (n  6–7).
B: intravenous administration of ACh caused a dose-dependent increase in
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combination of these compounds had a significant effect on ACh-induced
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0.05).
L525MACROPHAGES IN OP-INDUCED AIRWAY HYPERREACTIVITY
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00381.2012 • www.ajplung.org
This study supports the hypothesis that release of TNF- from
alveolar macrophages mediates parathion-induced airway hy-
perreactivity. Transcript levels of TNF- were significantly
elevated in BAL macrophages from guinea pigs exposed to
parathion, and ex vivo exposure to parathion increased release
of TNF- from alveolar macrophages isolated from untreated
guinea pigs. Lastly, pretreatment with the TNF- inhibitor
etanercept blocked parathion-induced airway hyperreactivity.
Whereas IL-1 mRNA was also increased in alveolar macro-
phages exposed to parathion in vivo, pretreatment with the
IL-1 receptor inhibitor anakinra did not prevent parathion-
induced airway hyperreactivity. This is likely not due to
insufficient levels of anakinra because we previously showed
that this dose of anakinra prevented vagally mediated airway
hyperreactivity in guinea pigs after ozone exposure (56). Thus
parathion-induced airway hyperresponsiveness is not mediated
by a general upregulation of inflammatory mediators but is
mediated selectively by TNF- from macrophages.
Here we show that parathion has direct effects on macro-
phages as evidenced by increased release of TNF- from
alveolar macrophages exposed to parathion ex vivo. The ob-
servation that parathion increased TNF- mRNA in alveolar
macrophages exposed in vivo, whereas ex vivo exposure in-
creased TNF- release but not mRNA expression, suggests
that parathion influences macrophages via direct and indirect
effects. Other inflammatory cells may contribute to parathion-
induced airway hyperreactivity in vivo. For example, our
preliminary observations (P. Lein and A. Grodzki, unpublished
observations) and other data (44) show that OPs activate mast
cells. Mast cells release several mediators that modulate mac-
rophage function (43) and airway smooth muscle contractility
(37). Determining whether mast cells contribute to parathion-
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Fig. 7. Pretreatment with the TNF- antagonist etanercept (Etn) prevented parathion-induced airway hyperreactivity. A: electrical stimulation of the vagus nerves
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induced airway hyperreactivity is a focus of ongoing research
in our laboratories.
Loss of M2 receptor function contributes to airway hyper-
reactivity in some patients with asthma (34) and mediates
hyperreactivity in animals that are antigen challenged (16),
exposed to ozone (18), virus infected (12), or exposed to OPs
(14, 32). In all these models, treatments that protect or restore
M2 receptor function also prevent or reverse airway hyperre-
activity. Consistent with our previous reports (14, 32), para-
thion caused M2 muscarinic receptor dysfunction, measured as
the inability of gallamine to potentiate vagally induced bron-
choconstriction. Pretreatment with etanercept, not only pre-
vented airway hyperreactivity, but also protected neuronal M2
receptor function. These data, together with the finding that
neither parathion nor etanercept alter intravenous ACh-induced
bronchoconstriction, suggest that TNF- is mediating parathi-
on-induced airway hyperreactivity at the level of the nerve.
Etanercept is used clinically to treat arthritis and plaque
psoriasis, which are disorders characterized by inflammation.
Inflammation is also a characteristic of asthma, and anti-
TNF- therapy reduces airway hyperreactivity and frequency
exacerbation in patients with severe steroid refractory asthma
(5, 24), particularly in patients with increased TNF- (5). Our
data predict that etanercept could be a potential therapy for
OP-induced airway hyperreactivity and asthma.
There is an increasing recognition that OPs cause toxic
effects independent of AChE inhibition via mechanism(s) that
include immunomodulation (1, 26, 39, 44). In this study, our
data support other studies showing that OPs, specifically para-
thion, modulate macrophages. However, unlike other studies,
we show that this interaction has a significant deleterious effect
on airway function, specifically through the release of macro-
phage TNF- but not macrophage IL-1. Furthermore, we
show that it is the parent compound, parathion, but not the
metabolite that inhibits AChE, paraoxon, that increases TNF-
release from alveolar macrophages exposed in culture. This
concurs with our previous studies (32, 41) that show parathion
causes airway hyperreactivity at doses lower than those re-
quired to inhibit AChE activity in the blood, brain, or lung.
That the parent compound may be responsible for non-AChE
effects is consistent with a recent paper demonstrating that
parathion was more potent than paraoxon in producing geno-
toxicity (25). Understanding how OP parent compounds and
metabolites affect non-AChE targets will improve regulatory
policies regarding the safe use of these pesticides because
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current exposure limits are based on AChE activity in the
blood.
There is widespread human exposure to OPs, both in agri-
cultural and urban settings (30, 33). The data presented here
may have important implications for the role of OPs in asthma,
especially in agricultural workers (23) and inner city children
(8). Our study presents a mechanism whereby OPs activate
macrophages to release TNF-, resulting in loss of inhibitory
M2 muscarinic receptor function on airway parasympathetic
nerves. Macrophages and muscarinic receptors control impor-
tant physiological functions in the brain, heart, gastrointestinal
tract, and urogenital system. Although we have not examined
M2 receptor function in the central nervous system or other
parasympathetic target organs, there is no reason to suspect
that OP-induced activation of macrophages and subsequent
loss of neuronal M2 function is limited to the lungs.
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